BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 26051516)

  • 41. A porcine circovirus type 2 (PCV2) mutant with 234 amino acids in capsid protein showed more virulence in vivo, compared with classical PCV2a/b strain.
    Guo L; Fu Y; Wang Y; Lu Y; Wei Y; Tang Q; Fan P; Liu J; Zhang L; Zhang F; Huang L; Liu D; Li S; Wu H; Liu C
    PLoS One; 2012; 7(7):e41463. PubMed ID: 22829951
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Emergence of a novel mutant PCV2b variant associated with clinical PCVAD in two vaccinated pig farms in the U.S. concurrently infected with PPV2.
    Opriessnig T; Xiao CT; Gerber PF; Halbur PG
    Vet Microbiol; 2013 Apr; 163(1-2):177-83. PubMed ID: 23305615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative efficacy of three commercial PCV2 vaccines in conventionally reared pigs.
    Lyoo K; Joo H; Caldwell B; Kim H; Davies PR; Torrison J
    Vet J; 2011 Jul; 189(1):58-62. PubMed ID: 20691624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A candidate DNA vaccine encoding a fusion protein of porcine complement C3d-P28 and ORF2 of porcine circovirus type 2 induces cross-protective immunity against PCV2b and PCV2d in pigs.
    Hou Z; Wang H; Feng Y; Li Q; Li J
    Virol J; 2019 May; 16(1):57. PubMed ID: 31046793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlates of Protection Following Vaccination with Inactivated Porcine Circovirus 2 Vaccines.
    Zanotti C; Martinelli N; Lelli D; Amadori M
    Viral Immunol; 2015 Dec; 28(10):600-8. PubMed ID: 26401584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancement of the immunogenicity of a porcine circovirus type 2 DNA vaccine by a recombinant plasmid coexpressing capsid protein and porcine interleukin-6 in mice.
    Guo XQ; Wang LQ; Qiao H; Yang XW; Yang MF; Chen HY
    Microbiol Immunol; 2015 Mar; 59(3):174-80. PubMed ID: 25664504
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus.
    Tian D; Sooryanarain H; Matzinger SR; Gauger PC; Karuppannan AK; Elankumaran S; Opriessnig T; Meng XJ
    J Gen Virol; 2017 Dec; 98(12):3026-3036. PubMed ID: 29091579
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Porcine Circovirus Type 2 (PCV2) Vaccines in the Context of Current Molecular Epidemiology.
    Karuppannan AK; Opriessnig T
    Viruses; 2017 May; 9(5):. PubMed ID: 28481275
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccination with a Porcine Reproductive and Respiratory Syndrome (PRRS) Modified Live Virus Vaccine Followed by Challenge with PRRS Virus and Porcine Circovirus Type 2 (PCV2) Protects against PRRS but Enhances PCV2 Replication and Pathogenesis Compared to Results for Nonvaccinated Cochallenged Controls.
    Niederwerder MC; Bawa B; Serão NV; Trible BR; Kerrigan MA; Lunney JK; Dekkers JC; Rowland RR
    Clin Vaccine Immunol; 2015 Dec; 22(12):1244-54. PubMed ID: 26446422
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Experimental infection of 3-week-old conventional colostrum-fed pigs with porcine circovirus type 2 and porcine parvovirus.
    Ostanello F; Caprioli A; Di Francesco A; Battilani M; Sala G; Sarli G; Mandrioli L; McNeilly F; Allan GM; Prosperi S
    Vet Microbiol; 2005 Jul; 108(3-4):179-86. PubMed ID: 15916871
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathologic and virologic findings in mid-gestational porcine foetuses after experimental inoculation with PCV2a or PCV2b.
    Saha D; Lefebvre DJ; Van Doorsselaere J; Atanasova K; Barbé F; Geldhof M; Karniychuk UU; Nauwynck HJ
    Vet Microbiol; 2010 Sep; 145(1-2):62-8. PubMed ID: 20395077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Porcine reproductive and respiratory syndrome virus (PRRSV) influences infection dynamics of porcine circovirus type 2 (PCV2) subtypes PCV2a and PCV2b by prolonging PCV2 viremia and shedding.
    Sinha A; Shen HG; Schalk S; Beach NM; Huang YW; Meng XJ; Halbur PG; Opriessnig T
    Vet Microbiol; 2011 Sep; 152(3-4):235-46. PubMed ID: 21641124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of porcine parvovirus vaccination on the development of PMWS in segregated early weaned pigs coinfected with type 2 porcine circovirus and porcine parvovirus.
    Opriessnig T; Fenaux M; Yu S; Evans RB; Cavanaugh D; Gallup JM; Pallares FJ; Thacker EL; Lager KM; Meng XJ; Halbur PG
    Vet Microbiol; 2004 Mar; 98(3-4):209-20. PubMed ID: 15036529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the effectiveness of passive (dam) versus active (piglet) immunization against porcine circovirus type 2 (PCV2) and impact of passively derived PCV2 vaccine-induced immunity on vaccination.
    Opriessnig T; Patterson AR; Madson DM; Pal N; Ramamoorthy S; Meng XJ; Halbur PG
    Vet Microbiol; 2010 May; 142(3-4):177-83. PubMed ID: 19913369
    [TBL] [Abstract][Full Text] [Related]  

  • 55. First identification of Porcine Circovirus Type 2b mutant in pigs from Uruguay.
    Ramos N; Mirazo S; Castro G; Arbiza J
    Infect Genet Evol; 2015 Jul; 33():320-3. PubMed ID: 26004195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protective immunity in swine induced by Porcine Circovirus 2b inactivated vaccines with different antigen payload.
    Guarneri F; Tresoldi ET; Sarli G; Boniotti MB; Lelli D; Barbieri I; Bacci B; D'Annunzio G; Amadori M
    Vet Microbiol; 2021 Jan; 252():108887. PubMed ID: 33276254
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic and immunogenicity analysis of porcine circovirus type 2 strains isolated in central China.
    Liu C; Liu Y; Chen H; Feng H; Chen Y; Wang Y; Wang J; Liu D; Deng R; Zhang G
    Arch Virol; 2018 Apr; 163(4):937-946. PubMed ID: 29305646
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparative efficacy test of 1
    Do DT; Tran KDV; Quach AT; Lee D; Chang FC; Wu CP; Tat TN; Chae C
    Can J Vet Res; 2021 Apr; 85(2):93-100. PubMed ID: 33883815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunity Elicited by an Experimental Vaccine Based on Recombinant Flagellin-Porcine Circovirus Type 2 Cap Fusion Protein in Piglets.
    Zhu S; Zhang C; Wang J; Wei L; Quan R; Yang J; Yan X; Li Z; She R; Hu F; Liu J
    PLoS One; 2016; 11(2):e0147432. PubMed ID: 26848967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2.
    Horlen KP; Dritz SS; Nietfeld JC; Henry SC; Hesse RA; Oberst R; Hays M; Anderson J; Rowland RR
    J Am Vet Med Assoc; 2008 Mar; 232(6):906-12. PubMed ID: 18341450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.